Oxbridge Re (OXBR) Competitors $2.17 -0.10 (-4.41%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$2.15 -0.02 (-0.69%) As of 07/3/2025 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OXBR vs. HIT, AAME, ZBAO, HUIZ, FGF, AIFU, CNFR, TIRX, UNAM, and XHGShould you be buying Oxbridge Re stock or one of its competitors? The main competitors of Oxbridge Re include Health In Tech (HIT), Atlantic American (AAME), Zhibao Technology (ZBAO), Huize (HUIZ), Fundamental Global (FGF), AIFU (AIFU), Conifer (CNFR), Tian Ruixiang (TIRX), Unico American (UNAM), and XChange TEC.INC. (XHG). These companies are all part of the "insurance" industry. Oxbridge Re vs. Its Competitors Health In Tech Atlantic American Zhibao Technology Huize Fundamental Global AIFU Conifer Tian Ruixiang Unico American XChange TEC.INC. Oxbridge Re (NASDAQ:OXBR) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability. Is OXBR or HIT more profitable? Health In Tech has a net margin of 0.00% compared to Oxbridge Re's net margin of -143.80%. Health In Tech's return on equity of 0.00% beat Oxbridge Re's return on equity.Company Net Margins Return on Equity Return on Assets Oxbridge Re-143.80% -41.78% -23.85% Health In Tech N/A N/A N/A Which has stronger earnings & valuation, OXBR or HIT? Health In Tech has higher revenue and earnings than Oxbridge Re. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOxbridge Re$550K29.35-$2.73M-$0.30-7.23Health In Tech$22.38M2.08N/AN/AN/A Do insiders and institutionals have more ownership in OXBR or HIT? 5.6% of Oxbridge Re shares are held by institutional investors. 19.5% of Oxbridge Re shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate OXBR or HIT? Oxbridge Re presently has a consensus target price of $5.00, suggesting a potential upside of 130.41%. Health In Tech has a consensus target price of $2.50, suggesting a potential upside of 193.81%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts clearly believe Health In Tech is more favorable than Oxbridge Re.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oxbridge Re 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Health In Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Does the media prefer OXBR or HIT? In the previous week, Health In Tech had 1 more articles in the media than Oxbridge Re. MarketBeat recorded 1 mentions for Health In Tech and 0 mentions for Oxbridge Re. Health In Tech's average media sentiment score of 0.01 beat Oxbridge Re's score of 0.00 indicating that Health In Tech is being referred to more favorably in the news media. Company Overall Sentiment Oxbridge Re Neutral Health In Tech Neutral SummaryHealth In Tech beats Oxbridge Re on 9 of the 13 factors compared between the two stocks. Get Oxbridge Re News Delivered to You Automatically Sign up to receive the latest news and ratings for OXBR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OXBR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OXBR vs. The Competition Export to ExcelMetricOxbridge ReINS IndustryFinance SectorNASDAQ ExchangeMarket Cap$16.08M$26.88B$12.09B$9.04BDividend YieldN/A1.11%5.53%4.02%P/E Ratio-7.2337.8520.0320.25Price / Sales29.354.9525.69118.60Price / CashN/A33.8221.6858.07Price / Book3.194.972.285.67Net Income-$2.73M$835.90M$1.00B$249.21M7 Day Performance24.00%1.12%2.22%3.28%1 Month Performance41.83%3.12%4.60%5.56%1 Year Performance-3.98%3.61%538.59%21.13% Oxbridge Re Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OXBROxbridge Re3.1661 of 5 stars$2.17-4.4%$5.00+130.4%-2.7%$16.08M$550K-7.233Gap DownHigh Trading VolumeHITHealth In TechN/A$0.88+6.4%$2.50+184.1%N/A$48.11M$22.38M0.0079AAMEAtlantic American0.5221 of 5 stars$2.13+4.4%N/A+46.8%$41.61M$188.23M-23.66140News CoverageZBAOZhibao TechnologyN/A$1.01-1.0%N/A-75.3%$32.15M$25.27M0.00148News CoverageGap UpHUIZHuize1.399 of 5 stars$2.10+0.5%$2.30+9.5%-91.9%$21.08M$171.10M-5.001,640FGFFundamental Global1.204 of 5 stars$16.00-0.1%N/A-31.4%$20.37M$17.35M12.219Gap UpAIFUAIFUN/A$6.04+3.4%N/AN/A$16.91M$247.81M8.274,707Gap UpCNFRConiferN/A$0.73-8.1%N/A-16.8%$9.65M$67.27M0.37150Positive NewsTIRXTian Ruixiang0.8048 of 5 stars$1.18-4.1%N/A-44.6%$890K$3.22M0.0050Positive NewsUNAMUnico AmericanN/A$0.07-13.7%N/AN/A$430KN/A0.0040Gap DownHigh Trading VolumeXHGXChange TEC.INC.N/A$1.28-6.6%N/AN/A$20K$41.09M0.0030Gap Up Related Companies and Tools Related Companies HIT Alternatives AAME Alternatives ZBAO Alternatives HUIZ Alternatives FGF Alternatives AIFU Alternatives CNFR Alternatives TIRX Alternatives UNAM Alternatives XHG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OXBR) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxbridge Re Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxbridge Re With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
